Insulin Directly Modulates Pain-Sensing Neurons Through Neuropeptide Interactions
Insulin receptors co-localize with TRPV1, CGRP, and Substance P on sensory neurons, with visceral neurons expressing more insulin receptors than somatic ones.
Quick Facts
What This Study Found
Insulin receptors are expressed on a specific subset of sensory neurons in both the central and peripheral nervous system. Quantitative studies revealed that visceral (organ-supplying) sensory neurons express more insulin receptors than somatic (skin/muscle) sensory neurons.
InsR co-localizes with TRPV1 (a pain channel), CGRP, and substance P in these neurons. This co-expression means insulin signaling can directly modulate pain transmission and neurogenic inflammation.
The functional significance includes modulation of ion channels involved in pain, regulation of neuropeptide release (CGRP and substance P), and neurotrophic effects on nerve growth, development, and regeneration. Recent studies reveal important roles for insulin in axonal growth and repair.
Key Numbers
InsR co-localizes with TRPV1, CGRP, substance P; visceral > somatic InsR expression; modulates pain, inflammation, nerve growth
How They Did This
This is a review article summarizing immunohistochemical, electrophysiological, and molecular studies on insulin receptor expression and function in primary sensory neurons, with focus on co-localization with pain-related channels and neuropeptides.
Why This Research Matters
Diabetic patients commonly experience altered pain sensitivity and nerve damage (neuropathy). Understanding how insulin directly affects pain-sensing neurons through neuropeptide pathways could explain these symptoms and lead to targeted treatments.
The finding that visceral sensory neurons are particularly enriched in insulin receptors explains why organs like the pancreas and bladder are especially vulnerable to inflammation in metabolic disease.
The Bigger Picture
Diabetic neuropathy and altered pain sensitivity are among the most common complications of diabetes. This review provides the molecular explanation: insulin directly modulates the same neurons and neuropeptides that control pain. Loss of insulin signaling in these neurons could drive diabetic neuropathy.
What This Study Doesn't Tell Us
This is a review article synthesizing existing data. Many of the findings are from animal studies, and the extent to which they translate to human patients is not fully established.
The functional consequences of InsR-neuropeptide interactions in specific disease states remain to be directly tested.
Questions This Raises
- ?Could insulin treatment directly reduce diabetic neuropathy pain?
- ?Does insulin resistance in neurons precede clinical neuropathy?
- ?Why do visceral neurons have more insulin receptors?
Trust & Context
- Key Stat:
- InsR + CGRP + SP insulin receptors are physically co-located with pain neuropeptides on sensory neurons, directly linking insulin signaling to pain modulation
- Evidence Grade:
- Review-level evidence synthesizing immunohistochemical, electrophysiological, and molecular studies. Most data from animal studies.
- Study Age:
- Published in 2020. Insulin's direct neuronal effects are being further investigated for diabetic neuropathy treatment.
- Original Title:
- Modulation of Sensory Nerve Function by Insulin: Possible Relevance to Pain, Inflammation and Axon Growth.
- Published In:
- International journal of molecular sciences, 21(7) (2020)
- Authors:
- Lázár, Bence András, Jancsó, Gábor, Sántha, Péter
- Database ID:
- RPEP-04976
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
How does diabetes cause nerve pain?
Insulin receptors are directly on pain-sensing neurons, co-located with pain molecules like CGRP and Substance P. When insulin signaling fails in diabetes, these neurons malfunction, leading to the burning pain, numbness, and tingling of diabetic neuropathy.
Could insulin help treat nerve pain?
Potentially. If insulin directly modulates pain neurons, restoring insulin signaling could reduce neuropathy. Some studies are exploring intranasal insulin and other targeted approaches for diabetic nerve pain.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-04976APA
Lázár, Bence András; Jancsó, Gábor; Sántha, Péter. (2020). Modulation of Sensory Nerve Function by Insulin: Possible Relevance to Pain, Inflammation and Axon Growth.. International journal of molecular sciences, 21(7). https://doi.org/10.3390/ijms21072507
MLA
Lázár, Bence András, et al. "Modulation of Sensory Nerve Function by Insulin: Possible Relevance to Pain, Inflammation and Axon Growth.." International journal of molecular sciences, 2020. https://doi.org/10.3390/ijms21072507
RethinkPeptides
RethinkPeptides Research Database. "Modulation of Sensory Nerve Function by Insulin: Possible Re..." RPEP-04976. Retrieved from https://rethinkpeptides.com/research/lazar-2020-modulation-of-sensory-nerve
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.